Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
Department of Medicine, Division of Allergy and Immunology, Northwestern University Feinberg School of Medicine, Chicago, Ill.
J Allergy Clin Immunol Pract. 2018 Sep-Oct;6(5):1446-1453. doi: 10.1016/j.jaip.2018.04.030.
The workup of a patient found to have eosinophilia should follow a thorough path with a detailed history and physical examination aimed at eliciting eosinophilic organ involvement, followed by histological confirmation whenever possible. The differential diagnosis of hypereosinophilia is extensive, but a rational approach beyond the history and physical examination including serologic, blood, and bone marrow cell analyses, genetic testing, and radiologic imaging can distinguish many of the causes. Often input from specialists (eg, hematology, dermatology, pulmonary, gastroenterology, and neurology) can help narrow down the possibilities and eventually result in a specific diagnosis. An accurate diagnosis is key to choosing the optimal treatment for a particular condition, and this is certainly true for eosinophilic disorders. Myeloid neoplasms that present with eosinophilia, for example, may respond to medicines that the allergist may be less accustomed to using, such as immunosuppressive agents and kinase inhibitors. Similarly, newly approved biologics that target IL-5 and eosinophils may provide new options for management. What follows is a case-based approach that helps to underscore key features of diagnosis, management, and follow-up when faced with a patient with a potential eosinophil-related disorder.
对于发现嗜酸粒细胞增多的患者,应进行全面的检查,包括详细的病史和体格检查,以确定嗜酸粒细胞受累的器官,并尽可能进行组织学确认。嗜酸粒细胞增多症的鉴别诊断范围广泛,但除了病史和体格检查之外,还包括血清学、血液和骨髓细胞分析、基因检测和影像学检查等合理的方法,可以区分许多病因。通常,专家(如血液科、皮肤科、呼吸科、消化科和神经科)的意见可以帮助缩小可能性范围,并最终确定特定的诊断。准确的诊断是选择特定疾病最佳治疗方法的关键,对于嗜酸粒细胞疾病尤其如此。例如,表现为嗜酸粒细胞增多的髓系肿瘤可能对过敏症医生不太熟悉的药物(如免疫抑制剂和激酶抑制剂)有反应。同样,新批准的针对白细胞介素 5 和嗜酸粒细胞的生物制剂也可能为治疗提供新的选择。以下是一种基于病例的方法,可以帮助强调在面对潜在的与嗜酸粒细胞相关的疾病患者时的诊断、治疗和随访的关键特征。